TERF2IP and neoplasm: MiR-1246 targets telomere repeat-binding factor 2-interacting protein (TERF2IP), significantly promoting M2 macrophage polarization by activating STAT3 and inhibiting the NF-κB pathway, leading to enhanced tumor proliferation, migration, and invasion.